Kinase targets and drugs remain an area of significant interest across academia and in the pharmaceutical industry. There are now many marketed drugs which target kinases and a growing number of compounds are currently in various stages of clinical development. This book covers the key areas for kinase inhibition that will be important over the coming years. This will be an important reference for scientists involved in drug discovery in academia or industry, particularly in oncology research.